Hook & thesis
IBEX Limited is no longer just a traditional BPO operator. Recent quarterly strength and a public push into AI-powered CX products - notably the Wave iX suite - have the potential to shift the company from services-driven revenue growth to software-assisted, higher-margin expansion. The market already reacted: strong fiscal 2026 results and bullish fiscal 2027 guidance produced meaningful upside. For traders, that combination of accelerating revenue, measurable margin improvement and a lightweight balance sheet offers a defined, actionable long opportunity with asymmetric upside.
My trade idea: initiate a long position at an entry of $46.50, place a stop loss at $42.00, and target $64.00 within a long-term horizon (180 trading days). The thesis rests on continued conversion of clients to AI-enabled CX solutions, revenue guidance execution, and room for valuation multiple expansion from current levels.
What IBEX does and why the market should care
IBEX provides technology-enabled customer lifecycle experience solutions across digital marketing, lead generation, online sales, billing, technical support, multi-lingual omni-channel services and retention/renewals. Over the past two years management has emphasized AI and automation - packaging capabilities like AI Virtual Agent, Translate and Verify & Route into the Wave iX product family aimed at utilities, healthcare and other verticals that want to modernize customer service while cutting operating costs.
Why that matters: AI-driven CX converts a percentage of IBEX revenue from labor-intensive seat-based services to software-augmented offerings that scale more efficiently. The result should be two-fold: higher revenue per client (through new digital/AI product bookings) and margin expansion as automation reduces the cost-to-serve.
Concrete numbers backing the argument
- Recent results: Q4 fiscal 2026 revenue was $164 million, up 12% year-over-year, and the company delivered its sixth consecutive quarter of double-digit growth.
- FY2025 base: IBEX reported record annual revenue of $558.3 million and adjusted EPS of $2.75 (up 31% YoY), indicating upward momentum in both top-line and profitability.
- Management guidance: Fiscal 2027 revenue is projected at $700-715 million (implying mid-to-high single digit to low double-digit growth depending on base timing) with adjusted EBITDA guidance of $90-94 million. Delivering that would materially expand EBITDA vs historical levels.
- Balance sheet & cash flow: Market capitalization sits around $607 million, enterprise value ~ $575 million, free cash flow was $31.2 million, and debt-to-equity is essentially immaterial at ~0.01, providing financial optionality for investment in product development or M&A.
- Valuation metrics: P/E is in the low-teens (~13x), EV/EBITDA ~7.7x and EV/Sales ~0.89x. Those multiples are attractive for a company that can grow revenue and expand margins via AI product adoption.
Valuation framing
At a market cap of approximately $607M against trailing revenue near $558M, IBEX trades at roughly 1.1x trailing revenue and under 8x EV/EBITDA. For a BPO with a pathway to higher-margin AI-enabled services, that looks conservative. If management hits the low end of guidance - say $700M revenue and $90M adjusted EBITDA - the implied EV/EBITDA would be even cheaper assuming modest EV growth. The stock has room to re-rate under two scenarios: organic multiple expansion as investors attribute higher recurring or product-like revenue to the business, and margin expansion that boosts reported EBITDA and FCF conversion.
Qualitatively, peers in the CX and BPO space that have successful SaaS or AI adjacencies often trade at higher multiples reflecting durable revenue and higher gross margins. IBEX is an arguable beneficiary if adoption of Wave iX products accelerates.
Trade plan (actionable)
- Entry: $46.50.
- Stop-loss: $42.00 (protects from a material breakdown and is placed above the 50-day structural support level near $40 to allow for noise but cut losses before bigger trend failure).
- Target: $64.00.
- Direction: Long.
- Horizon: long term (180 trading days) - allow time for two quarters of execution, broader market digestion of AI-driven revenue mix, and multiple re-rating. Expect to revisit at each quarterly release or if management updates guidance.
Why these levels? Entry at $46.50 is a reasonable buy near recent trade levels, leaving room for short-term volatility. The stop at $42.00 limits downside to roughly 9.7% from entry while sitting below short-term moving averages and above the 50-day SMA to avoid being shaken out by normal pullbacks. A $64 target represents about 37.6% upside from entry and anticipates both execution on guidance and a modest multiple expansion from low-teens P/E and sub-8x EV/EBITDA to mid-teens P/E territory, justified if AI products gain traction.
Catalysts to watch
- Quarterly earnings that beat revenue and margin expectations and provide concrete bookings/repeatable revenue metrics for Wave iX - next two reported quarters are pivotal.
- Large-vertical customer wins in utilities or healthcare where Wave iX is deployed at scale; public case studies are a credibility multiplier.
- Conference demonstrations and client pilots converting to paid contracts, particularly around the IUCX and CCW events where IBEX is showcasing AI CX solutions.
- Gross margin improvement and better free cash flow conversion documented on quarterly calls - showing automation is reducing cost-to-serve.
Risks and counterarguments
Every trade has risks. Below are the main ones and a counterargument to the bull case:
- Execution risk: Management’s fiscal 2027 revenue target of $700-715M and adjusted EBITDA $90-94M must be executed. Failure to convert pilots to recurring revenue would blunt the thesis.
- Customer concentration / contract churn: BPOs often face renewal risk and pricing pressure; losing a large account or seeing churn could rapidly impact margins.
- Technology integration and competition: AI CX is a crowded field. Larger software and cloud incumbents could outcompete IBEX on product features or pricing, slowing adoption.
- Valuation compression risk: If macro sentiment shifts and multiple contraction occurs, even good execution may not translate into immediate upside.
- Short-term technical pullback: The RSI is elevated (~68), suggesting near-term consolidation is possible before a sustained move higher.
Counterargument: It’s reasonable to argue IBEX will remain primarily a people-driven BPO for an extended period. If AI uptake is slower than management projects, revenue growth will come mostly from seat-based services with limited margin improvement, keeping multiples anchored and limiting upside. In that scenario the stock merits a lower valuation and the trade would struggle to reach the $64 target.
How I’ll know I’m wrong
I’ll reassess the thesis if any of the following occur: (1) management withdraws fiscal 2027 guidance or significantly lowers its Wave iX bookings commentary; (2) gross margins decline or free cash flow deteriorates quarter-over-quarter; (3) material client losses are disclosed; or (4) the company announces a strategic pivot away from AI products. The protective stop is set to limit losses if the market delivers clear evidence of failed execution.
Valuation snapshot
| Metric | Value |
|---|---|
| Market Cap | $607,000,000 |
| Trailing Revenue (FY2025) | $558.3M |
| EV / Sales | ~0.9x |
| EV / EBITDA | ~7.7x |
| P / E | ~13x |
| Free Cash Flow | $31.2M |
Conclusion - clear stance
I am constructive and recommend a long at $46.50 with a stop at $42.00 and a target of $64.00 over a long-term (180 trading days) horizon. The combination of accelerating top-line, a clean balance sheet, demonstrable margin upside from AI deployments and attractively low multiples creates a favorable risk-reward. Success hinges on tangible proof points: recurring Wave iX contract rollouts, sequential margin improvement, and the company's ability to convert demos into multi-year agreements.
If IBEX continues to show quarter-over-quarter growth and expands adjusted EBITDA in line with guidance, I would look to add on weakness and tighten stops as the business proves it can scale AI-enabled CX as a higher-margin revenue stream. Conversely, missed guidance, widening churn or deteriorating cash flow would force a rethink and likely an exit ahead of the stop level.
Key events to monitor
- Quarterly earnings calls and any commentary on Wave iX bookings or client conversion rates.
- Public customer deployments from IUCX / CCW showcases and any announced utility or healthcare contracts.
- Trends in gross margins and FCF over the next two quarters.
Trade with defined size and manage position risk. IBEX is a classic trade where operational execution and narrative (AI adoption) must meet in the middle to drive multiple expansion. For disciplined traders, the entry, stop and target above offer a pragmatic way to express that view.